Skip to main content

Table 2 Treatments and clinical outcomes of patients by group

From: Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients

 

HD-CRB n = 34 (100 %)

Non-HD-CRB n = 184 (100 %)

p

Treatment (within 48 h)

   

 Catheter removal

27 (79.4)

155 (84.2)

.555

 Vancomycin therapy

28 (82.3)

78 (42.4)

<.001

 Appropriate ATB therapya

31 (91.2)

118 (64.1)

.002

Outcome

   

 Persistent bacteraemia 3d

5 (14.7)

37 (20.1)

.463

 Persistent bacteraemia 7d

2 (5.9)

26 (14.1)

.533

 Complicated bacteraemia

11 (32.4)

89 (48.4)

.095

 Distant secondary focus

5 (15.2)

38 (20.7)

.465

 Endocarditis

0

10 (5.4)

.368

 Recurrence

3 (8.8)

4 (2.2)

.076

 Early mortality (48 h)

0

7 (3.8)

.599

 Overall mortality (30d)

4 (11.8)

49 (27.2)

.081

  1. aATB therapy: Antibiotic therapy